ArticleBlood cancer journal2026

Clinicomolecular features and clonal evolution of KMT2A-PTD AML: prognostic impact of concurrent FLT3-ITD under 2022 ELN risk stratification.

Yi-Tsung Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.